# Di-ya Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/di-ya-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 270 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 7 |
| i10-index | 5 |
| Last Known Institution | Zhengzhou University |
| OpenAlex ID | https://openalex.org/A5058950492 |
| Works | 11 |

## Researcher papers

- [Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/risk-of-pneumonitis-and-pneumonia-associated-with-immune-checkpoint-inhibitors/)
- [Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma](https://scholariq.org/papers/serum-level-of-co-expressed-hub-mirnas-as-diagnostic-and-prognostic-biomarkers/)
- [The risk of immune-related endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review and meta-analysis](https://scholariq.org/papers/the-risk-of-immune-related-endocrine-disorders-associated-with-anti-pd-1/)
- [Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis](https://scholariq.org/papers/hepatic-re-resection-versus-transarterial-chemoembolization-for-the-treatment-of/)
- [Risk of Ophthalmic Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis](https://scholariq.org/papers/risk-of-ophthalmic-adverse-events-in-patients-treated-with-immune-checkpoint/)
- [Effects of a nurse-led motor function rehabilitation training program for patients with ischemic stroke and family caregivers: study protocol for a randomized controlled trial](https://scholariq.org/papers/effects-of-a-nurse-led-motor-function-rehabilitation-training-program-for/)
- [Non-invasive glucose measuring apparatus based on conservation of energy method](https://scholariq.org/papers/non-invasive-glucose-measuring-apparatus-based-on-conservation-of-energy-method/)
- [Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysis](https://scholariq.org/papers/prevalence-and-risks-of-severe-events-for-cancer-patients-with-covid-19/)
- [Sirt1 ameliorated cardiac autophagic flux blockage via Prx2 during myocardial ischemia/reperfusion injury](https://scholariq.org/papers/sirt1-ameliorated-cardiac-autophagic-flux-blockage-via-prx2-during-myocardial/)
- [Risk of ophthalmic adverse events in patients treated with immune checkpoint inhibitor regimens: A systematic review and meta-analysis](https://scholariq.org/papers/risk-of-ophthalmic-adverse-events-in-patients-treated-with-immune-checkpoint-2/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Stroke Rehabilitation and Recovery](https://scholariq.org/topics/stroke-rehabilitation-and-recovery/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Researcher university

- [Zhengzhou University](https://scholariq.org/institutions/zhengzhou-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.